Home/Filings/4/0001104659-23-005104
4//SEC Filing

Ianelli Christopher 4

Accession 0001104659-23-005104

CIK 0001558569other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 6:32 PM ET

Size

9.6 KB

Accession

0001104659-23-005104

Insider Transaction Report

Form 4
Period: 2023-01-03
Ianelli Christopher
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Option

    2023-01-0684510,000 total
    Exercise: $1.00Exp: 2023-01-22Common Stock (845 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-06$1.00/sh+845$845425,359 total
  • Award

    Option

    2023-01-03$1.41/sh+10,000$14,10010,845 total
    Exercise: $1.41Exp: 2033-01-03Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.
  • [F2]Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated Stock Incentive Plan. The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.
  • [F3]Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.
  • [F4]Represents remaining granted stock options across all grants.

Issuer

iSpecimen Inc.

CIK 0001558569

Entity typeother

Related Parties

1
  • filerCIK 0001857027

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:32 PM ET
Size
9.6 KB